Tag: Prescription Drugs
Bisphosphonates Safe but May Not Improve Bone Marrow Lesion Volume
However, a trend was seen toward a decrease in bone marrow lesion volume
Drug Combo Prolongs Survival in Acute Myeloid Leukemia
Findings seen for azacitidine + venetoclax in older patients ineligible for intensive chemotherapy
Gilead Seeks FDA Approval for Remdesivir
Trials of the drug show that it can cut recovery time from COVID-19 by nearly a third
Longer Bisphosphonate Drug Holiday May Up Fracture Risk
For those with previous vertebral fracture, major osteoporotic fractures increased with holidays >12 months
Short-Term Risk for Below-Knee Amputation Not Increased With SGLT2i
Risk for below-knee amputation not increased versus DPP-4 inhibitor use in patients with type 2 diabetes
Relapse Rates Lower With Ofatumumab in Multiple Sclerosis
Annualized relapse rates lower for ofatumumab versus teriflunomide in two identical phase 3 trials
Early Use of IL-6 Inhibitors May Improve COVID-19 Outcomes
Mortality, risk for intubation lower with IL6ri use in severe COVID-19 stage IIB versus stage III
CV Meds Underused in Hispanics With Peripheral Artery Disease
For all classes of cardiovascular medications, lowest use seen for individuals of Mexican background
β2-Agonists Improve Nonaerobic Athletic Performance
Specifically, sprint and strength performance were enhanced with use of β2-agonists
More Than One in Three Stroke Survivors Have Uncontrolled HTN
80.4 percent of stroke survivors take antihypertensive medications, most commonly ACEi, ARB
